Insulet Corporation
PODD
$1.74 (1.12%)
1D
1W
3M
1Y
5Y
ALL
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 7 days ago • PODD
Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • 14 days ago • PODD
Insulet Corporation (PODD) Q1 2026 Earnings Call Transcript
Zacks Investment Research • 14 days ago • PODD
Insulet (PODD) Loses 17.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks Investment Research • 14 days ago • PODD
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
Investors Business Daily • 14 days ago • PODD
Insulin Pump-Maker Jumps On Beat And Raise
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.